and industry certainly overcomes limitations, improves the field, makes it more cost‐effective, and minimizes the negative results that contribute to poor human and environmental health. For human health certain nanoparticles, such as CNTs, quantum dots, and nanosilica, have been used in medicine and agriculture to develop safer and cost‐effective technologies. For the environment, nanoparticles have been used to improve the air and water quality, minimize the negative consequences of the automotive and construction industry, and enhance the process of energy conversion, a field that will need to be developed further due to the constant decline in natural resources. Using nanoparticles certainly comes with the risk of toxicity, which will require further testing to create a set of centralized regulations for their use around the world.
The research done so far on nanoparticles is excellent in creating a fascinating path to a safer, cleaner, and more economically sufficient planet; however, as mentioned before, further assessments of the long‐term effects of the involvement of nanotechnology certainly needs to be done to make sure that the mistakes that were made before under the greed of operating new technology are not repeated.
References
1 1 Rodrigue, J.‐P. (2020). Chapter 4: transportation, energy and environment. In: The Geography of Transport Systems, 456. New York: Routledge.
2 2 Mata, T.M., Caetano, N.S., and Martins, A.A. (2015). Sustainability evaluation of nanotechnology processing and production. Chemical Engineering Transactions 45: 1969–1974.
3 3 Sargent, J.F. (2014). The national nanotechnology initiative: overview, reauthorization, and appropriations issues. In: National Nanotechnology Initiative Overview & Strategic Plan (ed. J.F. Sargent Jr.), 1. Congressional Research Service.
4 4 Roco, M.C., Mirkin, C.A., and Hersam, M.C. (2011). Nanotechnology research directions for societal needs in 2020: summary of international study. Journal of Nanoparticle Research 13: 897–919.
5 5 Wang, G. (2018). Nanotechnology: The New Features. arXiv.
6 6 Shrestha, M. (2012). Nanotechnology to revolutionize medicine. Journal of Drug Delivery and Therapeutics 2: 156–161. https://doi.org/10.22270/jddt.v2i5.302.
7 7 Globocan Observatory W (2019). Cancer Today ‐ World. International Agency for Research on Cancer 876: 2018–2019.
8 8 Shi, S., Zhou, M., Li, X. et al. (2016). Synergistic active targeting of dually integrin αvβ3/CD44‐targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies. Journal of Controlled Release 235: 1–13.
9 9 Ilyin, S.E., Belkowski, S.M., and Plata‐Salamán, C.R. (2004). Biomarker discovery and validation: technologies and integrative approaches. Trends in Biotechnology 22: 411–416.
10 10 Goossens, N., Nakagawa, S., Sun, X., and Hoshida, Y. (2015). Cancer biomarker discovery and validation. Translational Cancer Research 4: 256–269.
11 11 Rhea, J.M. and Molinaro, R.J. (2011). Cancer biomarkers: surviving the journey from bench to bedside. Medical Laboratory Observer 43: 10–12, 16, 18.
12 12 Choi, Y.E., Kwak, J.W., and Park, J.W. (2010). Nanotechnology for early cancer detection. Sensors 10: 428–455.
13 13 Huang, X., Jain, P.K., El‐Sayed, I.H., and El‐Sayed, M.A. (2007). Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine 2: 681–693.
14 14 Liu, X., Dai, Q., Austin, L. et al. (2008). A one‐step homogeneous immunoassay for cancer biomarker detection using gold nanoparticle probes coupled with dynamic light scattering. Journal of the American Chemical Society 130: 2780–2782.
15 15 Zheng, T., Pierre‐Pierre, N., Yan, X. et al. (2015). Gold nanoparticle‐enabled blood test for early stage cancer detection and risk assessment. ACS Applied Materials & Interfaces 7: 6819–6827.
16 16 Dreaden, E.C., Austin, L.A., MacKey, M.A., and El‐Sayed, M.A. (2012). Size matters: gold nanoparticles in targeted cancer drug delivery. Therapeutic Delivery 3: 457–478.
17 17 Singh, P., Pandit, S., Mokkapati, V.R.S.S. et al. (2018). Gold nanoparticles in diagnostics and therapeutics for human cancer. International Journal of Molecular Sciences 19: 1–16.
18 18 Vines, J.B., Yoon, J.H., Ryu, N.E. et al. (2019). Gold nanoparticles for photothermal cancer therapy. Frontiers in Chemistry 7: 1–16.
19 19 Ali, M.R.K., Wu, Y., Ghosh, D. et al. (2017). Nuclear membrane‐targeted gold nanoparticles inhibit cancer cell migration and invasion. ACS Nano 11: 3716–3726.
20 20 Iannazzo, D., Pistone, A., Salamò, M. et al. (2017). Graphene quantum dots for cancer targeted drug delivery. International Journal of Pharmaceutics 518: 185–192.
21 21 Zhao, M.X., Zhu, B.J., Yao, W.J., and Chen, D.F. (2016). Therapeutic effect of quantum dots for cancer treatment. RSC Advances 6: 113791–113795.
22 22 McHugh, K.J., Jing, L., Behrens, A.M. et al. (2018). Biocompatible semiconductor quantum dots as cancer imaging agents. Advanced Materials 30: 1706356.
23 23 Ranjbar‐Navazi, Z., Eskandani, M., Johari‐Ahar, M. et al. (2018). Doxorubicin‐conjugated D‐glucosamine‐ and folate‐ bi‐functionalisedInP/ZnS quantum dots for cancer cells imaging and therapy. Journal of Drug Targeting 26: 267–277.
24 24 Luo, M., Cheng, W., Zeng, X. et al. (2019). Folic acid‐functionalized black phosphorus quantum dots for targeted chemo‐photothermal combination cancer therapy. Pharmaceutics 11: 242.
25 25 Chen, B.Q., Kankala, R.K., Zhang, Y. et al. (2020). Gambogic acid augments black phosphorus quantum dots (BPQDs)‐based synergistic chemo‐photothermal therapy through downregulating heat shock protein expression. Chemical Engineering Journal 390: 124312.
26 26 Shang, Y., Wang, Q., Wu, B. et al. (2019). Platelet‐membrane‐camouflaged black phosphorus quantum dots enhance anticancer effect mediated by apoptosis and autophagy. ACS Applied Materials & Interfaces 11: 28254–28266.
27 27 Sahoo, N.G., Bao, H., Pan, Y. et al. (2011). Functionalized carbon nanomaterials as nanocarriers for loading and delivery of a poorly water‐soluble anticancer drug: a comparative study. Chemical Communications 47: 5235–5237.
28 28 Iijima, S. (1991). Helical microtubules of graphitic carbon. Nature 354: 56–58.
29 29 Son, K.H., Hong, J.H., and Lee, J.W. (2016). Carbon nanotubes as cancer therapeutic carriers and mediators. International Journal of Nanomedicine 11: 5163–5185.
30 30 Elhissi, A.M.A., Ahmed, W., Hassan, I.U. et al. (2012). Carbon nanotubes in cancer therapy and drug delivery. Journal of Drug Delivery 2012: 1–10.
31 31 Xie, J., Teng, L., Yang, Z. et al. (2013). A polyethylenimine‐linoleic acid conjugate for antisense oligonucleotide delivery. BioMed Research International 2013: 1–7.
32 32 De Faria, P.C.B., Dos Santos, L.I., Coelho, J.P. et al. (2014). Oxidized multiwalled carbon nanotubes as antigen delivery system to promote superior CD8+ T cell response and protection against cancer. Nano Letters 14: 5458–5470.
33 33 Hassan, H.A.F.M., Diebold, S.S., Smyth, L.A. et al. (2019). Application of carbon nanotubes in cancer vaccines: achievements, challenges and chances. Journal of Controlled Release 297: 79–90.
